RAC1 and cancer: Treatment of endometrial cancer (Ishikawa cells) with Uro-A (20 μM) significantly decreased the activity and mRNA levels of Rac1 and PAK1, and this resulted in actin depolymerization, which is associated with a decreased cancer cell proliferation and migration (91).